Lund, Sweden

Per Bygren

This inventor holds 1 USPTO granted patent. Top assignee: Biocarb Ab. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per Bygren. Retrieved from https://idiyas.com/inventor/per-bygren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Per Bygren: Innovator in IgA Nephropathy Diagnosis

Introduction

Per Bygren is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of IgA nephropathy. His innovative work has led to the development of a patented method that enhances the accuracy of diagnosing this kidney condition.

Latest Patents

Per Bygren holds a patent for a "Method and a kit for the diagnosis of IgA nephropathy." This patent represents a crucial advancement in the medical field, providing healthcare professionals with improved tools for diagnosing a condition that can lead to serious health complications.

Career Highlights

Throughout his career, Per Bygren has been associated with Biocarb AB, a company dedicated to developing innovative solutions in the healthcare sector. His work at Biocarb AB has allowed him to focus on research and development, contributing to advancements in medical diagnostics.

Collaborations

Per Bygren has collaborated with esteemed colleagues, including Bo Cederholm and Jorgen Wieslander. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of better healthcare solutions.

Conclusion

Per Bygren's contributions to the field of medical diagnostics, particularly through his patent for IgA nephropathy diagnosis, highlight his role as an influential inventor. His work continues to impact the healthcare industry positively, paving the way for improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…